The US Food and Drug Administration has postponed most overseas inspections through April citing federal travel restrictions. One industry expert advises companies to prepare strong documentation in case the FDA begins to remotely conduct paper-based inspections.
On 13 March, the coronavirus crisis reached a new level where President Trump declared it a national emergency allowing national,...